FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tift Mann

Research Profile

Chemicals & Drugs

Devices

Procedures

Concepts & Ideas

Disorders

Anatomy

Co-author Network

Publications

TOP 3
William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Robert D Safian; Michael R Jaff; John F Bresnahan; Malcolm Foster; J Michael Bacharach; Jay Yadav; James Joye; Subbarao Myla; Elias Kassab; J Tift Mann; Gary M Ansel
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial.
Jiro Aoki; Gary S Mintz; Neil J Weissman; Lazar Mandinov; Eberhard Grube; Keith D Dawkins; Stephen G Ellis; Joel Greenberg; Alan Yu; J Tift Mann; Louis Cannon; Patrick A Cambier; Gregg W Stone
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tift Mann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
International journal of cardiology 2012;157(1):96-101.
2010: Robert D Safian; Michael R Jaff; John F Bresnahan; Malcolm Foster; J Michael Bacharach; Jay Yadav; James Joye; Subbarao Myla; Elias Kassab; J Tift Mann; Gary M Ansel
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial.
Journal of interventional cardiology 2010;23(5):491-8.
2008: Jiro Aoki; Gary S Mintz; Neil J Weissman; Lazar Mandinov; Eberhard Grube; Keith D Dawkins; Stephen G Ellis; Joel Greenberg; Alan Yu; J Tift Mann; Louis Cannon; Patrick A Cambier; Gregg W Stone
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
The American journal of cardiology 2008;102(8):1009-16.
2008: Jiro Aoki; Gary S Mintz; Neil J Weissman; J Tift Mann; Louis Cannon; Joel Greenberg; Eberhard Grube; A R Zaki Masud; Joerg Koglin; Lazar Mandinov; Gregg W Stone
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
JACC. Cardiovascular interventions 2008;1(2):161-7.
2008: J Tift Mann
Femoral access bleeding complications remain an important cause of morbidity and mortality in patients undergoing interventional procedures.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(5):655; author reply 656.
2008: Frances O Wood; Elizabeth K Saylors; Joel E Schneider; R Lee Jobe; J Tift Mann
Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(4):533-8.
2006: Duane S Pinto; Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Roxana Mehran; Yingbo Na; Mark Turco; Ronald Caputo; Jeffrey J Popma; Donald E Cutlip; Mary E Russell; David J Cohen
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
Journal of the American College of Cardiology 2006;48(1):32-6.
2005: Gregg W Stone; Stephen G Ellis; Louis A Cannon; J Tift Mann; Joel D Greenberg; Douglas Spriggs; Charles O'Shaughnessy; Samuel DeMaio; Patrick Hall; Jeffrey J Popma; Joerg Koglin; Mary E Russell
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(10):1215-23.
2005: Simon R Dixon; J Tift Mann; Michael A Lauer; Paul N Casale; Eric J Dippel; Robert K Strumpf; Robert L Feldman; Wendy Shear; Jon R Resar; Stevan D Zimmer; William W O'Neill
A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial.
Journal of interventional cardiology 2005;18(4):233-41.
2005: Neil J Weissman; Joerg Koglin; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Michael Kutcher; S Chiu Wong; Warren Strickland; Michael Mooney; Mary E Russell; Stephen G Ellis; Gregg W Stone
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
Journal of the American College of Cardiology 2005;45(8):1201-5.
2005: Stephen G Ellis; Jeffrey J Popma; John M Lasala; Joerg Koglin; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Gregg W Stone
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
Journal of the American College of Cardiology 2005;45(8):1193-200.
2005: Elizabeth Bazemore; J Tift Mann
Problems and complications of the transradial approach for coronary interventions: a review.
The Journal of invasive cardiology 2005;17(3):156-9.
2004: Frances Wood; J Tift Mann; R Lee Jobe; Michael J Arrowood
Transradial subclavian and coronary stenting in a single procedure.
The Journal of invasive cardiology 2004;16(10):596-8.
2004: Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Circulation 2004;109(16):1942-7.
2004: Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
The New England journal of medicine 2004;350(3):221-31.
2002: Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;288(19):2411-20.